Laura Arranz

Clinical Characteristics, Associated Malignancies and Management of Primary Sclerosing Cholangitis in Inflammatory Bowel Disease Patients: A Multicentre Retrospective Cohort Study

Iván Guerra, Luís Bujanda, Jesús Castro et al. · Journal of Crohn s and Colitis · 2019 · 53 citations

Medicine, Oncology, Pathology +17

Relationship between body mass index, fat mass and lean mass with SF-36 quality of life scores in a group of fibromyalgia patients

Laura Arranz, Miguel Ángel Canela, Magda Rafecas · Rheumatology International · 2011 · 50 citations

Pharmacy, Nutritional Sciences, Psychometrics +10

Early treatment with anti‐tumor necrosis factor agents improves long‐term effectiveness in symptomatic stricturing Crohn’s disease

Iago Rodríguez–Lago, Javier del Hoyo, Alexandre Pérez‐Girbés et al. · United European Gastroenterology Journal · 2020 · 47 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +12

Comparative Study of the Effectiveness of Vedolizumab Versus Ustekinumab After Anti-TNF Failure in Crohn’s Disease (Versus-CD): Data from the ENEIDA Registry

María José García, Montserrat Rivero, A Fernández-Clotet et al. · Journal of Crohn s and Colitis · 2023 · 19 citations

Pharmacy, Immunology, Pharmacotherapy +15

Carotid Plaque Assessment Reclassifies Patients with Inflammatory Bowel Disease into Very-High Cardiovascular Risk

Alejandro Hernández-Camba, Marta Carrillo‐Palau, Laura Ramos et al. · Journal of Clinical Medicine · 2021 · 18 citations · Full text

Medicine, Cardiology, Risk Assessment +16